Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTED.L Regulatory News (TED)

  • There is currently no data for TED

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Dimensional Fund Advisors Ltd. : Form 8.3 - TED BAKER PLC - Ordinary Shares

20 Jul 2022 10:55

Dimensional Fund Advisors Ltd. : Form 8.3 - TED BAKER PLC - Ordinary Shares

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: Dimensional Fund Advisors Ltd. (“Dimensional”), in its capacity as investment manager and on behalf its affiliates who are also investment managers. Dimensional and its affiliates expressly disclaim beneficial ownership of the shares described in this form 8.3
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Ted Baker plc(GB0001048619)
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 19 July 2022
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A” N/AIf YES, specify which

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: 5p Ordinary Shares 
  Interests Short positions 
 Number % Number %
(1) Relevant securities owned and/or controlled: 2,007,692* 1.09%    
(2) Cash-settled derivatives:        
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:        
TOTAL: 2,007,692 1.09%    

*Dimensional Fund Advisors Ltd. and / or its affiliates do not control voting discretion for 7,782 shares.

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:  
Details, including nature of the rights concerned and relevant percentages:  

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security Purchase/sale Number of securities Price per unit
Ordinary shares Purchase 12,322 GBP 0.834931

(b) Cash-settled derivative transactions

Class of relevant security Product descriptione.g. CFD Nature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit
         

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Typee.g. American, European etc. Expiry date Option money paid/ received per unit
               

(ii) Exercise

Class of relevant security Product descriptione.g. call option Exercising/ exercised against Number of securities Exercise price per unit
         

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealinge.g. subscription, conversion Details Price per unit (if applicable)
       

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO

Date of disclosure: 20 July 2022
Contact name: Thomas Hone
Telephone number: 020 3033 3419

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
18th Mar 20228:20 amRNSDirector/PDMR Shareholding
18th Mar 20227:00 amRNSStatement re Possible Offer
7th Mar 20221:01 pmRNSHolding(s) in Company
23rd Feb 20227:00 amRNSQ4 2022 / Pre-close trading update
17th Dec 20213:04 pmRNSBoard composition
6th Dec 20217:00 amRNSJohn Barton
1st Dec 20214:56 pmRNSTotal Voting Rights
11th Nov 202110:48 amRNSReplacement Interim Results
11th Nov 20217:00 amRNSInterim Results
5th Nov 202112:04 pmRNSDirectorate Change
2nd Nov 20213:13 pmRNSBlock listing Interim Review
6th Oct 20214:17 pmRNSDirector/PDMR Shareholding
4th Oct 20217:00 amRNSNew Joint Broker
7th Sep 20217:00 amRNSQ2 Trading Update
4th Aug 20217:00 amRNSDirectorate Change
3rd Aug 202111:22 amRNSDirector/PDMR Shareholding
28th Jul 20213:12 pmRNSNotice of Results
28th Jul 20217:00 amRNSNotice of Q2 Trading Update
23rd Jul 20217:00 amRNSNew Global HQ
28th Jun 20217:00 amRNSNotice of AGM
17th Jun 20217:00 amRNSHolding(s) in Company
14th Jun 20217:00 amRNSFinal Results
9th Jun 20213:11 pmRNSChange to Full Year Results Date
25th May 20217:00 amRNSSuccessful bank refinancing
24th May 20217:00 amRNSChange to Full Year Results Date
13th May 20217:00 amRNSHolding(s) in Company
6th May 20212:54 pmRNSBlock listing Interim Review
29th Apr 202110:55 amRNSHolding(s) in Company
11th Mar 20217:00 amRNSTed Baker announces new territory licence deals
24th Feb 202112:30 pmRNSAdditional Listing
11th Feb 20217:00 amRNSNotice of Results
4th Feb 202110:01 amRNSTotal Voting Rights
8th Jan 20213:47 pmRNSNotice of Results
16th Dec 20206:35 pmRNSDirector/PDMR Shareholding
7th Dec 20207:00 amRNSInterim Results
10th Nov 20207:00 amRNSChange to Interim Results Date
3rd Nov 20205:07 pmRNSBlock listing Interim Review
2nd Nov 202011:49 amRNSHolding(s) in Company
26th Oct 202010:50 amRNSDirector/PDMR Shareholding
14th Oct 202011:31 amRNSNotice of Results
7th Oct 20204:56 pmRNSHolding(s) in Company
6th Oct 20202:34 pmRNSTotal Voting Rights
30th Sep 202010:17 amRNSDirector/PDMR Shareholding
4th Sep 20202:25 pmRNSDirector/PDMR Shareholding
2nd Sep 20204:26 pmRNSDirector/PDMR Shareholding
1st Sep 202010:10 amRNSDirectorate Change
18th Aug 20205:13 pmRNSDirector/PDMR Shareholding
4th Aug 202011:58 amRNSTotal Voting Rights
24th Jul 20205:54 pmRNSHolding(s) in Company
21st Jul 202012:17 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.